Research Article

Locally Transmitted Malaria Focus in Aswan Governorate, Upper Egypt

 

Asmaa El-Kady1, Osama Hussein Abdell1, Amal Mostafa2, Salah Mohammed Hussein3

1Department of Medical Parasitology, Faculty of Medicine, South Valley University; 2Department of Medical Parasitology, Faculty of Medicine, Sohag University; 3Department of Medical Parasitology, Faculty of Medicine, Al Azhar University, Egypt.

 

Editor | Muhammad Imran Rashid, Department of Parasitology, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Received | January 21, 2017; Accepted | February 24, 2017; Published | February 28, 2017

*Correspondence | Asmaa El-Kady, Department of Medical Parasitology, South Valley University, Egypt; Email: [email protected]

Citation | El-Kady A, Abdell OH, Mostafa A, Hussein SM (2017). Locally transmitted malaria focus in aswan governorate, upper egypt. J. Adv. Parasitol. 4(1): 23-27.

DOI | http://dx.doi.org/10.17582/journal.jap/2017/4.1.23.27

ISSN | 2311-4096

Copyright © 2017 El-Kady et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

Introduction

 

Malaria as a disease has been known in Egypt since ancient times (Massa et al., 2000). Malaria was endemic in almost all Governorates of the country but prevalence showed a marked decline by 1990, and regressedin most of the Governorates (WHO, 2004). Egypt was classified within group 2 of the EMR countries where malaria was firmly under control and aiming at eradication of the disease (World Malaria Report 2013). During 2010–2013, Egypt successfully eliminated malaria (maintained zero indigenous cases), but remained in the stage of prevention of re-introduction of malaria. (World Malaria Report, 2016)

 

In fact, the country had reports of introduced cases or limited outbreaks of indigenous cases (Kenawy, 2015). The last focus of malaria in Egypt was in El-Fayoum after which Egypt is free of internally acquired cases of malaria since 1998 (WHO, 2012). As all the recorded cases were imported mainly from Sudan (WHO, 2012). Re-emerging malaria often becomes a serious public health problem in many countries (Sharma, 1996).

 

Materials and methods

 

The present study is a retrospective study was conducted on a total of 37 cases from Aswan Governorate during the period from 26 May to 28 June 2014. Patients were presenting with symptoms suggestive of malaria as fever, rigors, headache or darkening of urine.

 

Blood samples were collected from all cases included in the study. Samples were collected by sterile syringes then evacuated in EDTA containing blood collecting tubes labeled with patient name and date of collection. Thin and thick blood films were immediately prepared and stained.

 

All cases incorporated into the present work were subjected to history taking including individual history: name, age, and residence, history of voyaging abroad, Present history (manifestations): rigors, fever, sweating, headache and darkening of urine and general examination for paleness and jaundice and abdominal examination for discovery of splenomegaly.

 

Thin and thick blood films examination for detection of different stages of malaria was done. Thin blood films were prepared according to (Cheesbrough, 1999), where a small drop of blood is placed near the frosted end of a clean glass slide. A second slide is used as a spreader,placing the spreader at a 45° angle and backing into the drop of bloodthe blood is streaked in a thin film over the slide. The slide is allowed to air-dry and is thensmears were air-dried, and then dipped into 100% methanol, we place a layer of stain in the bottom of a glass jar (about 3 mL), then add buffer to a level that will just cover the slides when they are in the jar. Stain at room temperature for about 20 minutes. Then remove slides, rinse by dipping a few times into plain buffer, then stand on end to dry. Blood films were then allowed to air-dry in a vertical position and examined under a light microscope X100.

 

Thick blood films were prepared according to (Salak et al., 1999) where a drop of blood was placed at the a clear end and use the edge of the smearing slide to spread the drop out to about a 1 cm circle. The thick smear will take longer to dry without fixative then the spot was stained with diluted Giemsa (1:20, vol/vol)for 20 min., the slides was washed by placing the film in buffered water for 3 min., then blood films were allowed to air-dry in a vertical position and were examined using a light microscope X100.

 

Statistical Analysis

 

Data was collected and data analysis was performed using SPSS software version 16 under windows 7.

 

Results

 

The total number of cases involved in the study was 37 cases. Their ages ranged from 2.5 to 90 year with mean of 23.76, median 19 and standard deviation of 18.75. Outof all cases, 23 cases were positive for malaria as shown in (Table 1).

 

As regards gender among the positive cases, 11 (47.8%) were males and 12 were females (52.2%) as shown in (Table 2).

 

Out of 23 positive cases , all cases had elevated body temperature (100 %) ,11 person (47.8 %) had rigors, 12 persons (52.2%) had headache ,1 person (4.3 %) had tachypnea ,4 persons (14.4%) had darkening of urine, 2 persons (8.6 %) had tachycardia with no cerebral coma (0%) as shown in (Table 3). It was found that 4 persons (14.4 %) had splenomegaly, and 23 persons (100 %) had palloras illustrated in (Table 3).

 

Table 1: Showing the result of examined cases.

 

Result	N	%
Negative	14	37.8
P . falciparum	1	2.7
P . vivax	22	59.5
Total	37	100.0

 

Table 2: Gender distribution among positive cases.

 

		Diagnosis
		P. falciparum		P. vivax		Total
		N	%	N	%	N	%
Sex	Male	1	4.4	11	47.8	12	52.2
	Female	0	0	11	47.8	11	47.8
Total		1	4.4	22	95.6	23	100

 

Microscopic examination of blood films of the 37 cases revealed presence of Plasmodium stages in 23 patients (62.2%). Different stages of plasmodium vivax was detected in 22 patients using thick and thin blood film while ring stages and gametocytes of Plasmodium falciparum were detected by thick blood film of one case as shown in the following (Figure 1, 2, 3, 4, 5).

 

 

 

Table 3: Showing distribution of symptoms and signs among cases

 

Presentation Diagnosis	Anemia	Fever	Rigors	Headache	Splenomegaly	Jaundice	Tachypnea	Tachycardia
P.falciparum	1	1	1	1	1	1	1	1
P. vivax	22	22	10	11	3	3	0	1
P. value	0.000	N.C	0.286	0.533	0.026	0.026	0.001	0.000

 

 

Discussion

 

The condition started on 26thMay 2014when a male patient aging 37 years from El Sheikh Mostafa village, Edfo District, Aswan Governorate, complained of fever. Hewas admitted to Edfo Fever Hospital and malaria was confirmed with peripheral blood examination which showed Plasmodium vivax infection.

 

Subsequent cases were discovered according to the clinical picture of patients which mainly include fever and darkening of urine. House to house survey was helpful in discovery of cases.

 

The total number of suspected patients (on basis of clinical presentation) was 38 cases. The number of confirmed cases was 23 patients, 22 were diagnosed as P. vivax and one old lady with P. falciparum infection,with equal rate of transmission in males and females where 11 were males and 12 females, individuals of all age categories were affected.

 

In the present study, fever was a symptom in all malaria positive patients and this agreed with several studies screening for the common clinical presentation of malaria (D’Acremont, 2010), and also in accordance with (Genton and D’ Acremont , 2001) who stated that most of malaria patients experience fever (>92%), chills (79%) and headaches (70%) . In addition, (Yaw et al., 2014) stated that in non-endemic areas, peripheral parasitaemia accompanied by fever could be used to define clinical malaria.

 

On the other hand, (Murray et al., 2007), stated that fever is not always a feature of malaria, and signs may be unusual with effective prophylaxis of malaria. Also, (Sakaria et al., 2013) reported that the usual presentation of malaria with febrile attacks is seen only in 50-70% of the patients.

 

None of the cases gave a history of travelling abroad to any of the neighboring malarious areas which suggests that the A swan outbreak of malaria was introduced following an imported case or cases from neighboring malarious areas followed by local transmission. A less likely source of the epidemic would have been relapse or recrudescence of P. vivax, as none ofthe patients reported prior history of malaria.

 

The diagnosis of cases was plasmodium vivax in 22 cases (95.7%) and only one old aged female with plasmodium falciparum infection representing (4.3%).

 

Patients received treatment in the form of a combination of (20 mg artemether and 120 mglumefantrine), twice daily with for 3 days ,then single dose of Primaquine (0.25 mg⁄ kg) was administered fromthe fourth day onwards until the 14th day, and after the blood film became negative for malaria,. The P. falciparum infected case was treated similarly.

 

Peripheral blood film examination was made daily for 3 consecutive days after treatment, and patients were not discharged until their blood films are negative for plasmodium malaria.

 

Reported cases of malaria in Egypt in the period from 1998 – 2010 were all imported as reported by (WHO, 2012; Daoud, 2003) about the distribution of malaria cases in Egypt reported by the Ministry of Health from 1998 – 2010 as illustrated in (Table 4 and 5).

 

Although it is difficult to have a significant outbreaks of malaria in Egypt the risk of localized outbreaks of introduced cases is present due to infection of local anopheline mosquitoes by imported cases as many anophyline spp. which serve as malaria vectors are present in Egypt as Anophyles pharoensis and Anophyles sergenti are the detected vectors in Egypt. Anophyles pharoensis is for the most part the vector of Plasmodium vivax while, An. sergenti is the vector of P. falcipaum (Wassim, 2014).

 

Table 4: Recorded Imported Malaria cases 1998-2003 in Egypt (Daoud, 2003).

 

Year	No of examined slides	Positive	P. vivax	P. falciparum
1998	32403	24	23	1
1999	28992	38	37	1
2000	26581	17	17	0
2001	26341	10	9	1
2002	25785	9	9	0
2003	23813	45	44	1

 

Table 5: Malaria in Egypt from 2004-2010 (WHO, 2012)

 

Year	Suspected cases	Examined microscopically	Confirmed microscopically	Imported cases
2004	43	43	43	43
2005	23		23	23
2006	29		29	29
2007	30	23402	30	30
2008	80	34880	80	80
2009	94	41344	94	94
2010	85	664294	85	85

 

Several factors increase the risk of reemerging malaria in Egypt including the continuous movement of people between Egypt and Sudan through Aswan governorate and the entrance of Asian and African peoples to Egypt for different purposes including educational and touristic purposes and anti-malarial drug resistance (Thomas and Nchinda, 1998). Other factors as water resources development projects (e.g. Toshka and El Salam Canal) also increases the risk. Several studies had linked environmental change caused by these projects and risk of arthropod-borne disease (Birley 1989).

 

Re-introduction of malaria has occurred in some Eastern Mediterranean Region countries that have been free of malaria. For instance, an imported case from Pakistan resulted in a small outbreak (30 cases of vivax malaria) in Jordan during 1990. In 1998, due to Somali refugees, a small outbreak (21 cases of falciparum malaria) occurred in Oman which had been free of falciparum malaria (but not vivax). Also, in Lebanon 2 small outbreaks of vivax malaria occurred during 1997–1998 (WHO, 2007).

 

In the European Region, local transmission from imported cases has been reported in Republic of Moldova (2003), Ukraine (2003), France (2006, 2008–2010), Italy (2007), Greece (2010) three locally transmitted cases were recorded, and Spain (2010).In all these instances, local outbreaks were limited to fewer than 10 cases (WHO, 2012)

 

In other parts of the world: three cases arising from local P. falciparum transmission were reported in Singapore in 2003; Oman, which interrupted transmission in 2004, has experienced several subsequent outbreaks of P. vivax and P. falciparum brought in by migrant workers from the Indian subcontinent; and Morocco, certified malaria-free in 2007, recorded two cases of “airport malaria” in 2009 (WHO, 2011).

 

AuTHOR’S CONTRIBUTION

 

Idea by Asmaa EL Kady, Osama Abdella. Asmaa EL Kady performed the laboratory works and collected data, Amal Mostafa and Salah Mohammed Hassan helped with the laboratory analysis of samples, collection of papers, data analysis and writing the manuscript and Osama Abdella , Asmaa EL Kady revised the manuscript.

 

Conflict of interest

 

We (the authors) declare that we all have no conflict of interest.

 

ACKNOWLEDGEMENTS

 

Our special acknowledgment to Dr. Magda El-Nazer, Professor of Medical Parasitology, Faulty of Medicine, Assuit University who helped us exammining the blood films of the patients.

 

Ethics Approval

 

This study was approved by the Institutional Ethics Review Board of the Faculty of Medicine, South Valley University, Qena, Egypt. Oral consent was obtained from the patients before they were recruited into the study.

 

References

 

Massa E. R., Cerutti N., Marin A., Savoia D., (2000). Malaria in ancient Egypt: paleoimmunological investigation onpredynastic mummified remains, Chungará (Arica). Revista de Antropología Chilena. 32: 7.

World Health Organization (2004). Africa malaria report, 2003. World Health Organization, Geneva, Switzerland.

Report on the tenth intercountry meeting of national malaria programme managers. Sharm El-Sheikh, Egypt 18–20 February 2013(http://applications.emro.who.int/docs/IC_Meet_ Rep_2013_EN_14905.pdf?ua=1, accessed 1 April 2016).

Report on the tenth intercountry meeting of national malaria programme managers. Sharm El-Sheikh, Egypt 18–20 February 2013. http://applications.emro.who.int/docs/IC_Meet_Rep_2013_EN_14905.pdf?ua=1, accessed 1 April 2016.

Kenawy MA. (2015). Review of anopheles mosquitoes and malaria in ancient and modern Egypt. J. Mosq. Res. 5(4):1–8. https://doi.org/10.5376/jmr.2015.05.0004

World Health Organization (2012): WHO Global Malaria Programme .World Health Organization, Geneva, Switzerland.

Sharma VP (1996). Re-emergence of malaria in India. Indian J. Med. Res. 103: 26-45.

Cheesbrough (1999). District laboratory practice in tropical countries. Cambridge: Cambridge University Press., 178-309.

Salak L.A.; Akinyanju O., Afolabi B.M. (1999). Comparison of the standard Giemsa –stained thick blood film with Quantative Buffy Coat Tecnique in malaria diagnosis in Nigeria. Niger Q. J. Hosp. Med. 9: 256-269.

D’Acremont V.; Lengeler C., Genton, B. (2010). Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar. J. 9:240. https://doi.org/10.1186/1475-2875-9-240

Genton B., D’Acremont V. (2001). Clinical features of malaria in returning travelers and migrants In : Travelers’ malaria. Schlagenhauf, P. Hamilton: BC Decker: 371–392.

Yaw a frane, Goufa Zhou, Andrew K Githeko, Guiyun Yan (2014). clinical malaria case definition and malaria attributable fraction in the highlands of western Kenya. Malaria Journal. 2014. 13: 405. https://doi.org/10.1186/1475-2875-13-405

Murray L., Ian W., Tom T., Chee K.C. (2007). Malaria: treatment and prophylaxis, cerebral malaria (Plasmodium falciparum), Oxford Hand Book of Clinical Medicine. Oxford University Press, England, 385.

Sakaria A., Mahajan, S., Desai R., Shah K. (2013). Delayed cerebellar ataxia: A rare self-limiting complication of Plasmodium falciparum malaria. Adv. Biomed. Res. 2:27.

Daoud A.I.E. (2003). Malaria situation in Egypt, formal report by Ministry of Health.

Wassim (2014). Secondary structure and sequence of ITS2-r DNA of the Egyptian malaria vector , Anophylespharoensis (Theobald) . J. Egypt. Soc. Parasitol. 44. 1:197-204.

Thomas C., Nchinda Malaria, (1998). A Reemerging Disease: in Africa, Emerging Infectious Diseases Vol. 4, No. 3, July–September.

Birley MH., (1989). Guidelines for forecasting the vector-borne disease implications of water resource development. Geneva, World Health Organization, (VBC/89.6).

Guidelines on prevention of the reintroduction of malaria. Cairo: WHO Regional Office for the Eastern Mediterranean; 2007 (EMRO Technical Publications Series, 34).

World Health Organization (2011). Guidelines for the treatment of malaria, (2):13–15. World Health Organization, Geneva, Switzerland.